Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
PET Clinics
|
March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
April 19, 2003
[Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells]
Yoshihito Minosako, Masahiro Nemoto, Sento Ino, et al.
International Journal of Molecular Sciences
|
November 13, 2025
Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer
Sifan Feng, Kentaro Hisada, Haruna Yorifuji, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 26, 2022
Dioxetane Derivative Containing Carboxy Group as a Chemiluminophore-Introducing Reagent
Yukie Nohara, Shun Masuda, Kazuko Kaneda-Nakashima, et al.
Nuclear Medicine and Biology
|
October 1, 2011
Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells
Shuntaro Oka, Hiroyuki Okudaira, Yasunori Yoshida, et al.
Nuclear Medicine and Biology
|
May 13, 2014
Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats
Masaru Kanagawa, Yoshihiro Doi, Shuntaro Oka, et al.
Brain Research
|
September 3, 2013
Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines
Masahiro Ono, Shuntaro Oka, Hiroyuki Okudaira, et al.
Bioengineering (Basel, Switzerland)
|
January 22, 2024
Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice
Atsushi Yagishita, Miho Katsuragawa, Shin'ichiro Takeda, et al.
Molecular Imaging and Biology
|
October 19, 2013
Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose
Shuntaro Oka, Hiroyuki Okudaira, Masahiro Ono, et al.
Seminars in Nuclear Medicine
|
October 1, 2025
Development of PSMA-Targeted Alpha Therapy Using [<sup>211</sup>At]PSMA-5
Tadashi Watabe, Sadahiro Naka, Yoshifumi Shirakami, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
PET Clinics
|
March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
April 19, 2003
[Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells]
Yoshihito Minosako, Masahiro Nemoto, Sento Ino, et al.
International Journal of Molecular Sciences
|
November 13, 2025
Astatine-211-Labeled Therapy Targeting Amino Acid Transporters: Overcoming Drug Resistance in Non-Small Cell Lung Cancer
Sifan Feng, Kentaro Hisada, Haruna Yorifuji, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 26, 2022
Dioxetane Derivative Containing Carboxy Group as a Chemiluminophore-Introducing Reagent
Yukie Nohara, Shun Masuda, Kazuko Kaneda-Nakashima, et al.
Nuclear Medicine and Biology
|
October 1, 2011
Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells
Shuntaro Oka, Hiroyuki Okudaira, Yasunori Yoshida, et al.
Nuclear Medicine and Biology
|
May 13, 2014
Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats
Masaru Kanagawa, Yoshihiro Doi, Shuntaro Oka, et al.
Brain Research
|
September 3, 2013
Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines
Masahiro Ono, Shuntaro Oka, Hiroyuki Okudaira, et al.
Bioengineering (Basel, Switzerland)
|
January 22, 2024
Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice
Atsushi Yagishita, Miho Katsuragawa, Shin'ichiro Takeda, et al.
Molecular Imaging and Biology
|
October 19, 2013
Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose
Shuntaro Oka, Hiroyuki Okudaira, Masahiro Ono, et al.
Seminars in Nuclear Medicine
|
October 1, 2025
Development of PSMA-Targeted Alpha Therapy Using [<sup>211</sup>At]PSMA-5
Tadashi Watabe, Sadahiro Naka, Yoshifumi Shirakami, et al.
Page
of 4